Published in Virus Weekly, November 23rd, 2004
"Rab GTPases and their effectors facilitate vesicular transport by tethering donor vesicles to their respective target membranes.
"Rab9 mediates late endosome to trans-Golgi transport and has recently been found to be a key cellular component for human immunodeficiency virus-1, Ebola, Marburg, and measles virus replication, suggesting that it may be a novel target in the development of broad spectrum antiviral drugs," scientists in the United States report.
"As part of our structure-based drug design program," said L.Q. Chen and coworkers, "we have determined the crystal...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Virus Weekly